ACADIA HEALTHCARE ($ACHC) posted quarterly earnings results for Q4 2025 on Wednesday, February 25th. The company reported earnings of $0.07 per share, beating estimates of $0.06 by $0.01. The company also reported revenue of $821,460,000, beating estimates of $816,065,871 by $5,394,129.
You can see Quiver Quantitative's $ACHC stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ACADIA HEALTHCARE Hedge Fund Activity
We have seen 142 institutional investors add shares of ACADIA HEALTHCARE stock to their portfolio, and 212 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SACHEM HEAD CAPITAL MANAGEMENT LP removed 4,215,000 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $59,810,850
- GOLDMAN SACHS GROUP INC added 3,815,471 shares (+417.8%) to their portfolio in Q4 2025, for an estimated $54,141,533
- JEFFERIES FINANCIAL GROUP INC. added 3,379,813 shares (+inf%) to their portfolio in Q4 2025, for an estimated $47,959,546
- DEERFIELD MANAGEMENT COMPANY, L.P. added 3,331,000 shares (+280.2%) to their portfolio in Q4 2025, for an estimated $47,266,890
- DME CAPITAL MANAGEMENT, LP added 2,478,493 shares (+150.9%) to their portfolio in Q4 2025, for an estimated $35,169,815
- UBS GROUP AG removed 2,358,607 shares (-54.4%) from their portfolio in Q4 2025, for an estimated $33,468,633
- WELLINGTON MANAGEMENT GROUP LLP added 2,350,760 shares (+24.9%) to their portfolio in Q4 2025, for an estimated $33,357,284
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ACADIA HEALTHCARE Analyst Ratings
Wall Street analysts have issued reports on $ACHC in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Keybanc issued a "Overweight" rating on 11/18/2025
- RBC Capital issued a "Outperform" rating on 11/12/2025
- Guggenheim issued a "Buy" rating on 11/10/2025
- UBS issued a "Buy" rating on 11/07/2025
- Raymond James issued a "Outperform" rating on 10/03/2025
To track analyst ratings and price targets for ACADIA HEALTHCARE, check out Quiver Quantitative's $ACHC forecast page.
ACADIA HEALTHCARE Price Targets
Multiple analysts have issued price targets for $ACHC recently. We have seen 14 analysts offer price targets for $ACHC in the last 6 months, with a median target of $18.5.
Here are some recent targets:
- Jason Cassorla from Guggenheim set a target price of $22.0 on 02/23/2026
- Brian Tanquilut from Jefferies set a target price of $15.0 on 01/22/2026
- Ryan Langston from TD Cowen set a target price of $22.0 on 01/16/2026
- Ben Hendrix from RBC Capital set a target price of $17.0 on 01/14/2026
- Ann Hynes from Mizuho set a target price of $17.0 on 12/18/2025
- Andrew Mok from Barclays set a target price of $14.0 on 12/04/2025
- Whit Mayo from Leerink Partners set a target price of $14.0 on 12/03/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
